Deana Carrico Case, M.S.CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2323 Fairview Rd, Galax, VA 24333 Phone: 276-236-2365 |
Alisha Chantay Isom Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 202 Painter St, Galax, VA 24333 Phone: 276-236-5164 |
Mrs. Kate Weatherman, MA,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 202 Painter St, Galax, VA 24333 Phone: 276-236-5154 Fax: 276-236-0699 |
Mikayla Hoch Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 225 Academy Dr, Galax, VA 24333 Phone: 276-236-6159 |
Dlp Twin County Regional Healthcare Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 607 Glendale Rd, Galax, VA 24333 Phone: 276-236-1675 Fax: 276-236-3399 |
Outpatient Rehabilitation Services Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 607 Glendale Rd, Galax, VA 24333 Phone: 276-236-1675 Fax: 276-236-3399 |
Sally Newman Hill, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 223 Long St, Galax, VA 24333 Phone: 276-236-2911 |
Meagan W Kennedy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3117 Glendale Rd, Galax, VA 24333 Phone: 336-200-0087 |
News Archive
CEL-SCI Corporation, a late-stage oncology company and a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases, announced today that it has retained the services of an international Contract Research Organization (CRO) to run CEL-SCI's upcoming Phase III clinical trial in advanced primary head and neck cancer with the Company's lead product candidate, Multikine®.
The University of Rochester will offer a new specialization within the current Master of Science in Teaching and Curriculum program for doctors, nurses and other health care professionals who want to teach or who want to expand their educational skills.
A prestigious National Institutes of Health (NIH) Transformative R01 Program grant for $4.9 million has been awarded to Case Western Reserve University School of Medicine. The five-year grant will fund research to identify patients' inborn genetic susceptibility to the development of colon cancer metastasis. Case Western Reserve was one of only 42 recipients of this competitive new grant designed to support exceptionally innovative, high risk, original and/or unconventional research projects that have the potential to create or overturn fundamental paradigms.
The Washington Post: "The next 48 hours will be critical to the fate of health-care reform in the Senate, as Democratic leaders struggle to settle disputes that stand in the way of holding a final vote this year on the massive package reports on the distance among senators that has to be bridged before a bill can pass."
› Verified 1 days ago